SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Auro Laboratories informs about newspaper cuttings

03 Aug 2022 Evaluate

With reference to Regulation 47 of SEBI [Listing Obligations and Disclosure Requirements] Regulation, 2015 (‘Listing Regulations’), Auro Laboratories has informed that it enclosed Newspaper cuttings of unaudited Financial Results of the Company for the quarter ended June 30, 2022, published in the Newspaper: Active Times, Mumbai (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper) dated August 03, 2022.

The above information is a part of company’s filings submitted to BSE.

Auro Laboratories Share Price

252.10 -2.30 (-0.90%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: